44-0605373 · Kansas City, MO
Excellence in healthcare for children
Total revenue
$2B
FY2023
Total expenses
$1.8B
FY2023
Net assets
$2.4B
FY2023
Operating margin
13%
NPLens analysis
FY18–FY2023 · from annual filings
Financial health
A-
Derived analysis — not an official IRS designation.
Computed from FY2023 · derived analysis
FY2023 · program vs. administration vs. fundraising (Form 990, Part IX)
FY2023 · where revenue comes from (as reported)
Highest-paid officers, directors & key employees · FY2023.
Paul D Kempinski MS FACHE
Director; President & CEO
$1,697,300
James O'Brien Jr MD
Physician
$1,605,878
William Douglas MD
Physician
$1,546,911
Shawn St Peter MD
SVP/Surgeon-in-Chief;ChairDeptOfSurg
$1,113,324
Thomas Curran PhD
SVP, CSO, Executive Director-CMRI
$1,054,516
Each figure on this page traces to one of these source returns.
Health scores, efficiency ratios, peer percentiles, and outlier flags are derived analysis by NPLens — not official IRS designations. Figures are as reported on the organization's Form 990 filings. How these are computed →